Quality Assistance contributes to Springer’s Mass Spectrometry of Glycoproteins
This publication was edited and partly written by Arnaud Delobel, R&D Director, in collaboration with 87 authors from 30 research laboratories all over the world.
L’objectif des 500 médicaments innovants est à l’horizon !
Ce challenge se poursuit en 2021 et est le fruit d’une réflexion collective et est porté par l’ensemble des collaborateurs de l’entreprise. C’est une grande fierté, pour chacun de nous, de jouer un rôle dans la mise sur le marché des médicaments de demain.
The European Pharmacopoeia Commission has recently appointed Arnaud Delobel as Member of MAB WP
It is a recognition of Arnaud Delobel’s scientific and technical expertise in the development of pharmaceutical analytical methods related to monoclonal antibodies and Quality Assistance is proud of his appointment by the EDQM as member of the WAB WP.
Partnership between Spectralys Biotech and Quality Assistance
A fruitful collaboration is born: Quality Assistance adds up FTIR to its wide range of analytical techniques for biomolecules and Spectralys Biotech can ensure the transition of its services to GMP phases.
What makes us different as an analytical CRO?
We are your reliable analytical partner. Always one step ahead!
Quality Assistance reinvests between 10 and 15% of its turnover each year in the development of its analytical expertise and operational equipment.
New developments in the absolute quantification of proteins
In order to upstream the application of this approach from early stages of the development, this method was optimised and validated using smaller amounts of sample demonstrating the same levels of precision and accuracy.
L'équipe de Quality Assistance soutient le Télévie !
Accélérer l'accès de la communauté aux médicaments de demain, c'est notre Vision !
Streamline analytical characterisation for biotherapeutics with the Multiple-Attribute Monitoring (MAM) approach
Critical Quality Attributes (CQAs) are typically defined early in development based on the quality target profile of the product. The complexity of the CQAs calls for the development of many different analytical methods.
Two-dimensional LC/MS is a powerful tool to speed up mAbs and ADCs development
Using 2D-LC/MS, it is now possible to get high-resolution MS data from non-MS compatible LC separations in a fully automated workflow.